AI-Powered blood test could spot five cancers before symptoms show
NCT ID NCT07186296
First seen Jun 26, 2026 · Last updated Jul 01, 2026 · Updated 2 times
Summary
This study is testing a new blood test called EXoPred that uses artificial intelligence and laser technology to find tiny particles from cancer cells. The goal is to detect breast, colon, pancreatic, ovarian, and lung cancers at an early stage. Researchers will enroll 1,400 people aged 45 and older who have or are suspected of having one of these cancers. The test is not yet proven and this study will help refine the algorithm for future use.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
EXoPred diagnostic test (blood test using AI and laser analysis of particles from cells)
What this could lead to
If successful, this could lead to a simple blood test that catches multiple cancers early, when they are easier to treat.
What could go wrong
This is an early-stage study focused on building and validating the test's algorithm. It may not yet be accurate enough for widespread use, and results need confirmation in larger, more diverse groups.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Albany Stratton VA Medical Center
RECRUITINGAlbany, New York, 12208, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Bronx Veterans Medical Research Foundation
RECRUITINGThe Bronx, New York, 10468, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
City of Hope Duarte Cancer Center
RECRUITINGLos Angeles, California, 91010, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
John Hopkins University
RECRUITINGBaltimore, Maryland, 21218, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
KCTL
RECRUITINGLouisville, Kentucky, 40202, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Lexington VA Healthcare System
RECRUITINGLexington, Kentucky, 40502, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Tibor Rubin VA Medical Center
RECRUITINGLong Beach, California, 90822, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of Hawaii Cancer Center
RECRUITINGHonolulu, Hawaii, 96813, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
VA Hudson Valley Healthcare System
RECRUITINGWappingers Falls, New York, 12590, United States
Contact Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••